(Q37832119)

24 August 2017

1 reference

title

Obesity in 2010: the future of obesity medicine: where do we go from here? (English)

1 reference

24 August 2017

0 references

Suzanne M Wright

1

1 reference

PubMed ID

21263435

24 August 2017

Louis J Aronne

series ordinal

2

1 reference

24 August 2017

1 February 2011

1 reference

Nature Reviews Endocrinology

24 August 2017

1 reference

24 August 2017

7

1 reference

24 August 2017

2

1 reference

24 August 2017

69-70

1 reference

https://scigraph.springernature.com/pub.10.1038/nrendo.2010.231

24 August 2017

0 references

cites work

Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.231

Sibutramine in cardiovascular disease: is SCOUT the new STORM on the horizon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.231

Multicenter, placebo-controlled trial of lorcaserin for weight management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.231

Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.231

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.231

Anorectics on trial: a half century of federal regulation of prescription appetite suppressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.231

21 January 2018

Identifiers

DOI

10.1038/NRENDO.2010.231

1 reference

24 August 2017

1 reference

PubMed ID

21263435